undefined undefined
NaN.000
NaN.00%
CARY, N.C., May 15, 2024 /PRNewswire/ -- Fathom Holdings, Inc. (Nasdaq: FTHM) ("Fathom" or the "Company"), a national, technology-driven, end-to-end real estate services platform, today cong...
05-16 04:05
Throughout the last three months, 6 analysts have evaluated Fathom Holdings (NA...
05-14 04:00
HC Wainwright & Co. analyst Yi Chen reiterates Veru (NASDAQ:VERU) with a Buy and maintains $3 price target.
05-13 17:47
Veru (NASDAQ:VERU) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. The company reported quarterly sales of $4.10 million which beat the analyst
05-08 18:33
CARY, N.C., May 6, 2024 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM) ("Fathom" or the "Company"), a national, technology-driven, end-to-end real estate services platform integrating r...
05-07 04:05
4 analysts have shared their evaluations of Veru (NASDAQ:VERU) during the recen...
05-06 21:01
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-03 23:50
CARY, N.C., May 2, 2024 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM) ("Fathom" or the "Company"), a national, technology-driven, end-to-end real estate services platform integrating r...
05-03 04:05
Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory
05-02 20:38
CARY, N.C., April 29, 2024 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM) ("Fathom" or the "Company"), a national, technology-driven, end-to-end real estate services platform integratin...
04-29 20:05